☰

Joseph E. Ippolito, Ph.D. - Publications

Affiliations: 
2007 Washington University, Saint Louis, St. Louis, MO 
Area:
Oncology, Biochemistry, Medical Biophysics
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Barashi NS, Li T, Angappulige DH, Zhang B, O'Gorman H, Nottingham CU, Shetty AS, Ippolito JE, Andriole GL, Mahajan NP, Kim EH, Mahajan K. Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. Cancers. 16. PMID 38201640 DOI: 10.3390/cancers16010213  0.379
2023 Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, ... ... Ippolito JE, et al. Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 1067-1096. PMID 37856213 DOI: 10.6004/jnccn.2023.0050  0.304
2022 Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, ... ... Ippolito JE, et al. NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 1288-1298. PMID 36509074 DOI: 10.6004/jnccn.2022.0063  0.316
2021 Pachynski RK, Kim E, Miheecheva N, Kotlov N, Ramachandran A, Postovalova E, Galkin I, Svekolkin V, Lyu Y, Zou Q, Cao D, Gaut JP, Ippolito JE, Bagaev A, Bruttan M, et al. Single cell spatial proteomic revelations on the multiparametric MRI heterogeneity of clinically significant prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33771855 DOI: 10.1158/1078-0432.CCR-20-4217  0.308
2021 Schaeffer E, Srinivas S, Antonarakis ES, Armstrong AJ, Bekelman JE, Cheng H, D'Amico AV, Davis BJ, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Horwitz EM, Ippolito JE, et al. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. Journal of the National Comprehensive Cancer Network : Jnccn. 19: 134-143. PMID 33545689 DOI: 10.6004/jnccn.2021.0008  0.309
2020 Weinreb J, Choyke P, Iagaru A, Ippolito J, Lockhart M, Merrick G, Sachdev S, Silva E, Taneja SS, Tempany C, Wahl R, Rosenkrantz A. ACR Stakeholder Prostate Summit. Journal of the American College of Radiology : Jacr. PMID 32360452 DOI: 10.1016/J.Jacr.2020.03.031  0.392
2019 Sur S, Nakanishi H, Flaveny C, Ippolito JE, McHowat J, Ford DA, Ray RB. Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract. Cell Communication and Signaling : Ccs. 17: 131. PMID 31638999 DOI: 10.1186/S12964-019-0447-Y  0.397
2019 Drake RR, Angel PM, Wu J, Pachynski RK, Ippolito JE. How else can we approach prostate cancer biomarker discovery? Expert Review of Molecular Diagnostics. PMID 31498690 DOI: 10.1080/14737159.2019.1665507  0.409
2019 Henning GM, Vetter JM, Drake BF, Ippolito JE, Shetty AS, Andriole GL, Kim EH. Diagnostic performance of prostate multiparametric magnetic resonance imaging in African-American men. Urology. PMID 31419432 DOI: 10.1016/J.Urology.2019.08.007  0.383
2019 Mason BR, Eastham JA, Davis BJ, Mynderse LA, Pugh TJ, Lee RJ, Ippolito JE. Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 506-513. PMID 31085758 DOI: 10.6004/Jnccn.2019.7306  0.39
2019 Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, et al. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 479-505. PMID 31085757 DOI: 10.6004/Jnccn.2019.0023  0.414
2019 Pickersgill NA, Vetter JM, Raval NS, Andriole GL, Shetty AS, Ippolito JE, Kim EH. The Accuracy of Prostate MRI Interpretation: Impact of the Individual Radiologist and Clinical Factors. Urology. PMID 30807773 DOI: 10.1016/J.Urology.2019.01.035  0.392
2019 Kim E, Cao D, Ippolito J, Pachynski R, Andriole G. Mp68-01 Immune Composition Contributes To Prostate Mri Appearance The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557016.26094.3B  0.35
2018 Bhat NR, Vetter JM, Andriole GL, Shetty AS, Ippolito JE, Kim EH. Magnetic Resonance Imaging-Defined Prostate-Specific Antigen Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy. Urology. PMID 30580005 DOI: 10.1016/J.Urology.2018.12.010  0.404
2018 Nguyen GK, Mellnick VM, Yim AK, Salter A, Ippolito JE. Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma. Radiology. 171504. PMID 29558292 DOI: 10.1148/Radiol.2018171504  0.348
2017 Ippolito JE, Yim AK, Luo J, Chinnaiyan P, Rubin JB. Sexual dimorphism in glioma glycolysis underlies sex differences in survival. Jci Insight. 2. PMID 28768910 DOI: 10.1172/Jci.Insight.92142  0.329
2017 Vargas HA, Huang EP, Lakhman Y, Ippolito JE, Bhosale P, Mellnick V, Shinagare AB, Anello M, Kirby J, Fevrier-Sullivan B, Freymann J, Jaffe CC, Sala E. Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group. Radiology. 161870. PMID 28641043 DOI: 10.1148/Radiol.2017161870  0.31
2016 Miyahira AK, Roychowdhury S, Goswami S, Ippolito JE, Priceman SJ, Pritchard CC, Sfanos KS, Subudhi SK, Simons JW, Pienta KJ, Soule HR. Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting. The Prostate. PMID 27679977 DOI: 10.1002/Pros.23260  0.434
2016 Ippolito JE, Brandenburg MW, Ge X, Crowley JR, Kirmess KM, Som A, D'Avignon DA, Arbeit JM, Achilefu S, Yarasheski KE, Milbrandt J. Extracellular pH Modulates Neuroendocrine Prostate Cancer Cell Metabolism and Susceptibility to the Mitochondrial Inhibitor Niclosamide. Plos One. 11: e0159675. PMID 27438712 DOI: 10.1371/Journal.Pone.0159675  0.457
2016 Som A, Bloch S, Ippolito JE, Achilefu S. Acidic extracellular pH of tumors induces octamer-binding transcription factor 4 expression in murine fibroblasts in vitro and in vivo. Scientific Reports. 6: 27803. PMID 27302093 DOI: 10.1038/Srep27803  0.368
2016 Som A, Raliya R, Akers W, Ippolito J, Singamaneni S, Biswas P, Achilefu S. Abstract LB-232: Nano-CaCO3 as a novel pH-sensitive nanoparticle platform for cancer therapy Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-232  0.315
2015 Loch R, Fowler K, Schmidt R, Ippolito J, Siegel C, Narra V. Prostate Magnetic Resonance Imaging: Challenges of Implementation Current Problems in Diagnostic Radiology. 44: 26-37. PMID 25073742 DOI: 10.1067/J.Cpradiol.2014.05.009  0.395
2014 Elhammali A, Ippolito JE, Collins L, Crowley J, Marasa J, Piwnica-Worms D. A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor. Cancer Discovery. 4: 828-39. PMID 24740997 DOI: 10.1158/2159-8290.Cd-13-0572  0.344
2014 Ippolito JE, Piwnica-Worms D. A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer. Plos One. 9: e88667. PMID 24551133 DOI: 10.1371/Journal.Pone.0088667  0.375
2006 Ippolito JE. Current concepts in neuroendocrine cancer metabolism. Pituitary. 9: 193-202. PMID 17001465 DOI: 10.1007/S11102-006-0264-3  0.418
2006 Ippolito JE, Merritt ME, Bäckhed F, Moulder KL, Mennerick S, Manchester JK, Gammon ST, Piwnica-Worms D, Gordon JI. Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers. Proceedings of the National Academy of Sciences of the United States of America. 103: 12505-10. PMID 16895983 DOI: 10.1073/Pnas.0605207103  0.574
2006 Giannakis M, Stappenbeck TS, Mills JC, Leip DG, Lovett M, Clifton SW, Ippolito JE, Glasscock JI, Arumugam M, Brent MR, Gordon JI. Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches. The Journal of Biological Chemistry. 281: 11292-300. PMID 16464855 DOI: 10.1074/Jbc.M512118200  0.658
2005 Ippolito JE, Xu J, Jain S, Moulder K, Mennerick S, Crowley JR, Townsend RR, Gordon JI. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proceedings of the National Academy of Sciences of the United States of America. 102: 9901-6. PMID 15998737 DOI: 10.1073/Pnas.0500756102  0.621
2004 Syder AJ, Karam SM, Mills JC, Ippolito JE, Ansari HR, Farook V, Gordon JI. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proceedings of the National Academy of Sciences of the United States of America. 101: 4471-6. PMID 15070742 DOI: 10.1073/Pnas.0307983101  0.693
2002 Hu Y, Ippolito JE, Garabedian EM, Humphrey PA, Gordon JI. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. The Journal of Biological Chemistry. 277: 44462-74. PMID 12228243 DOI: 10.1074/Jbc.M205784200  0.602
Show low-probability matches.